Search research articles
Contact Us
Filters
Showing results (21-30 of 84) with videos related to
Page
of 9
Sort By:
Genes, Chromosomes & Cancer
|
April 19, 2011
Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20
Tobias Herold, Vindi Jurinovic, Medhanie Mulaw, et al.
Plos One
|
October 10, 2014
The NPM1 mutation type has no impact on survival in cytogenetically normal AML
Friederike Pastore, Philipp A Greif, Stephanie Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2009
ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays
Klaus H Metzeler, Annika Dufour, Tobias Benthaus, et al.
Journal of Hematology & Oncology
|
May 3, 2024
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model
Kellie J Archer, Han Fu, Krzysztof Mrózek, et al.
Clinical Colorectal Cancer
|
June 4, 2016
Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice
Martin Wilhelm, Lothar Mueller, M Craig Miller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 8, 2023
Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells
Elisabeth Meedt, Daniela Weber, Agnes Bonifacius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2009
Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome
Annika Dufour, Friederike Schneider, Klaus H Metzeler, et al.
Annals of Hematology
|
February 25, 2012
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients
Annika Dufour, Friederike Schneider, Eva Hoster, et al.
Haematologica
|
May 13, 2014
Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse
Max Hubmann, Thomas Köhnke, Eva Hoster, et al.
Cancer
|
October 22, 2022
Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis
Friederike Pastore, Alessandro Pastore, Maja Rothenberg-Thurley, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 84) with videos related to
Sort By:
Page
of 9
Genes, Chromosomes & Cancer
|
April 19, 2011
Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20
Tobias Herold, Vindi Jurinovic, Medhanie Mulaw, et al.
Plos One
|
October 10, 2014
The NPM1 mutation type has no impact on survival in cytogenetically normal AML
Friederike Pastore, Philipp A Greif, Stephanie Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2009
ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays
Klaus H Metzeler, Annika Dufour, Tobias Benthaus, et al.
Journal of Hematology & Oncology
|
May 3, 2024
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model
Kellie J Archer, Han Fu, Krzysztof Mrózek, et al.
Clinical Colorectal Cancer
|
June 4, 2016
Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice
Martin Wilhelm, Lothar Mueller, M Craig Miller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 8, 2023
Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells
Elisabeth Meedt, Daniela Weber, Agnes Bonifacius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2009
Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome
Annika Dufour, Friederike Schneider, Klaus H Metzeler, et al.
Annals of Hematology
|
February 25, 2012
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients
Annika Dufour, Friederike Schneider, Eva Hoster, et al.
Haematologica
|
May 13, 2014
Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse
Max Hubmann, Thomas Köhnke, Eva Hoster, et al.
Cancer
|
October 22, 2022
Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis
Friederike Pastore, Alessandro Pastore, Maja Rothenberg-Thurley, et al.
Page
of 9